Molecular Screening

Molecular Screening is a laboratory-based analytical process that identifies specific biomolecular markers indicative of early pathological changes, distinguishing it from broader diagnostic methods by its focus on detecting molecular-level alterations prior to clinical symptom onset.

3.6K

Publications

176.8K

Citations

22.5K

Authors

4.5K

Institutions

Publications per year

2017–2026

934

Authors

22.5K

  1. MH
    Michael H. Gelb

    University of Washington, United States

    22 publications · 1.5K citations

    19

    h-index

  2. PM
    Philip M. Farrell

    University of Wisconsin–Madison, United States

    15 publications · 1.8K citations

    14

    h-index

  3. PR
    Piero Rinaldo

    Mayo Clinic, United States

    15 publications · 839 citations

    14

    h-index

  4. MC
    Michele Caggana

    New York State Department of Health, United States

    13 publications · 554 citations

    13

    h-index

  5. JJ
    Joseph J. Orsini

    Wadsworth Center, United States

    14 publications · 602 citations

    13

    h-index

1–5 of 22.5K

Venues

  1. Clinical Chemistry

    128 publications · 7.1K citations

    46

    h-index

  2. PubMed

    Repository · 177 publications · 6K citations

    42

    h-index

  3. PLoS ONE

    96 publications · 4.9K citations

    38

    h-index

  4. SLAS DISCOVERY

    110 publications · 3.7K citations

    36

    h-index

  5. Human Mutation

    55 publications · 3.5K citations

    35

    h-index

1–5